Cognitive impairment is a debilitating side effect experienced by patients with cancer treated
with systemically administered anticancer therapies. With around 19.3 million new cases of …

Anthracyclines, a class of drugs considered as most effective anticancer drugs, used in the
various regimens of cancer chemotherapy, induce long-term impairment of mitochondrial …

Background Statins taken for cardiovascular indications by patients with breast cancer and
lymphoma during doxorubicin treatment may attenuate left ventricular ejection fraction …

Many cancer survivors suffer from chemotherapy-induced cognitive impairment known as
'Chemobrain'. Doxorubicin-topoisomerase II inhibitor-is widely used in breast cancer …

Chemotherapeutic agents such as doxorubicin, cyclophosphamide, fluorouracil, and
cisplatin are commonly used to treat a variety of cancers and often result in chemobrain …

Background Cancer survivors frequently experience cognitive impairments. This systematic
review assessed animal literature to identify artificial (pharmaceutical) or natural …

Cognitive dysfunction has been one of the most reported and studied adverse effects of
cancer treatment, but, for many years, it was overlooked by the medical community …

Aims The current study aimed to elucidate the neurotoxic potential of DOX to induce AD-like
pathology paying attention to the role of wingless-integrated/β-catenin (Wnt/β-catenin) …

Novel treatments, screening, and detection methods have prolonged the lives of numerous
cancer patients worldwide. Unfortunately, existing and many promising new …

The term “chemobrain” refers to the cognitive dysfunction that occurs after chemotherapy,
and it is also known as chemotherapy-induced cognitive impairment or “chemofog”. The aim …